Your browser doesn't support javascript.
loading
Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines.
Szebeni, Janos; Storm, Gert; Ljubimova, Julia Y; Castells, Mariana; Phillips, Elizabeth J; Turjeman, Keren; Barenholz, Yechezkel; Crommelin, Daan J A; Dobrovolskaia, Marina A.
Afiliación
  • Szebeni J; Nanomedicine Research and Education Center, Institute of Translational Medicine, Semmelweis University, Budapest, Hungary.
  • Storm G; SeroScience LCC, Budapest, Hungary.
  • Ljubimova JY; Department of Nanobiotechnology and Regenerative Medicine, Faculty of Health, Miskolc University, Miskolc, Hungary.
  • Castells M; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, the Netherlands.
  • Phillips EJ; Department of Biomaterials Science and Technology, University of Twente, Enschede, the Netherlands.
  • Turjeman K; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Barenholz Y; Terasaki Institute for Biomedical Innovation, Los Angeles, CA, USA.
  • Crommelin DJA; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Dobrovolskaia MA; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Nat Nanotechnol ; 17(4): 337-346, 2022 04.
Article en En | MEDLINE | ID: mdl-35393599
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Anafilaxia Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Nat Nanotechnol Año: 2022 Tipo del documento: Article País de afiliación: Hungria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Anafilaxia Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Nat Nanotechnol Año: 2022 Tipo del documento: Article País de afiliación: Hungria